Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivatives
- 9 July 2024
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 150, 107623
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Pyridazine and pyridazinone derivatives: Synthesis and in vitro investigation of their anti‐inflammatory potential in LPS‐induced RAW264.7 macrophagesDrug Development Research, 2024
- Pyridazine derivatives as selective COX‐2 inhibitors: A review on recent updatesDrug Development Research, 2023
- Challenges and Opportunities for Celecoxib RepurposingPharmaceutical Research, 2023
- The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative ReviewPain and Therapy, 2023
- New indomethacin analogs as selective COX‐2 inhibitors: Synthesis, COX‐1/2 inhibitory activity, anti‐inflammatory, ulcerogenicity, histopathological, and docking studiesArchiv der Pharmazie, 2020
- Synthesis and Pharmacological Evaluation of New Pyridazin‐Based Thioderivatives as Formyl Peptide Receptor (FPR) AgonistsDrug Development Research, 2013
- Synthesis and anti-inflammatory activity of novel pyridazine and pyridazinone derivatives as non-ulcerogenic agentsArchives of Pharmacal Research, 2012
- A clinical perspective of IL‐1β as the gatekeeper of inflammationEuropean Journal of Immunology, 2011
- Structure-based molecular design, synthesis, and in vivo anti-inflammatory activity of pyridazinone derivatives as nonclassic COX-2 inhibitorsMedicinal Chemistry Research, 2009
- Über die Kondensation von Lävulinsäure mit aromatischen AldehydenEuropean Journal of Inorganic Chemistry, 1956